Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU

Company Profile

Stronger Sell Today ADMA ranks #5103 as SELL CANDIDATE #5103 Weaker Sell

ADMA stock forecast ADMA Biologics Inc

ADMA stock forecast

ADMA Biologics Inc

465 Route 17 South

Ramsey, NJ 07446


Industry: Biotechnology

Sector: Healthcare


ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a plasma collection center. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank